Related Experiment Videos
Interim FDA report on intraocular lenses
Ophthalmology
|April 1, 1980
Summary
The anterior chamber intraocular lens shows more complications and lower visual acuity post-implantation compared to other lens types. Some intraocular lens complications were less frequent than in control cases.
Area of Science:
- Ophthalmology
- Medical Device Regulation
Background:
- Intraocular lenses (IOLs) have been regulated by the Food and Drug Administration (FDA) since 1978.
- Over 177,000 IOLs across four classes were implanted by August 1979.
Purpose of the Study:
- To analyze the safety and efficacy of different intraocular lens classes.
- To compare postoperative complications and visual acuity associated with anterior chamber IOLs versus other IOL types and control operations.
Main Methods:
- Analysis of data on 177,503 implanted intraocular lenses reported to the FDA.
- Comparison of complication rates and visual acuity between anterior chamber IOLs, other IOL classes, and control operations.
Main Results:
- Anterior chamber intraocular lenses demonstrated a higher incidence of specific postoperative complications.
- Lower visual acuity was observed with anterior chamber IOLs compared to control cases and other IOL classes in the first six months post-implantation.
- Certain complications occurred less frequently with intraocular lens implantation than in control cases.
Conclusions:
- The anterior chamber intraocular lens may be associated with increased risks and reduced visual outcomes.
- Further monitoring and analysis of intraocular lens safety and efficacy are warranted.